Xeris Pharmaceuticals, Inc.

Date of Award

12.03.2012

Program

Improve Outcomes

Amount

$928,700.00

Term of Grant

36 months

Project Title

Glucagon Mini-Dose Pen for the Treatment of Moderate Hypoglycemia